Abstract:
Title compds.(I, R = C1-3 alkyl; R1 = C3-6 alkyl, C5-9 cycloalkyl, alkylcycloalky, cycloalkenyl, bicyclohetyl, bicycloheptenyl, nortricyclyl, benzyl), useful for lowering the blood sugar concentration, were prepd. by reaction of compds. II(Z =halogen, hydroxy, o-alkali metal group) with III in the presence of acid-condensation agent. Thus, N- 4-(β-N'-methyl-N'-2-pyridylureidoethyl)-benzenesulfonyl -N'-cyclohexylurea was prepd. by reacting 3.2 g 4-(β-N'methyl-N'-pyridyl -ureidoethyl_-benzenesulfinic acid with 1.6 g N-cyclohexyl-N'-hydroxyurea in 40ml dioxane at 60≦̸C for 2hrs.
Abstract:
Benzenesulfonylureas (I; X = 2-quinolyl, 4-methyl-2-quinoyl, 2-pyridyl, R = Me, Et, Pr, R1 = alkyl, cycloalkyl, cycloalkylmethyl, Benzyl) were prepd. by heating 5.6g 4-(β-N'- 2-quinolyl-N'-methylureidoethyl)-benzenesulfonylmethylcarbamate and a mixt. of 1.lg cyclopentylamine and 75ml dioxane. When I was administered orally to rabbits at 10mg/kg, the blood sugar level was decreased by 4.3% after one hr, 49% after 24hr, and 18% after 47hr.
Abstract:
Title compds.(I, X = pyridyl, quinolyl, benzothiazolyl, etc. ; R = C1-3 alkyl; R1 = C3-6 alkyl, C5-9 cycloalkyl etc.), useful as hypoglycemic agent, were prepd. by treating compd. II with H2O. Thus, 2.4 g N-[4-β-N'-methyl-N'-2-pyridyl-ureid-oethyl) benzenesulfonyl -N' -cyclo hexylthiourea and 1.04 g dicyclohexyl-carbodiimide were treated at room temp. in 20 ml dioxane for several days and filtrated, following by adding 5ml H2O, and treated with steam to give N[4- (β-N'-methyl-N'-2-pyridyl-rureidoethyl)benzenesulfonyl -N'-cyclohexyl urea.
Abstract:
Benzenesulfonyl ures and its salts(I; x = pyridyl, pyrimidinyl, quinolyl, benzothiazolyl, benzoxazolyl; R = C1-3 alkyl; R1 = C3-6 alkyl, C5-9 cycloalkenyl, cycloalkenyl, bicycloheptyl, bicycloheptenyl, adamantyl, benzyl), useful as hyperglycemic agent, were prepd. by oxidn. of benzenesulfinyl urea and benzenesulfenyl uresa. Thus, 3.4 g 4-(β-(N'-methyl-N'-pyridyl -ureidoethyl)-benzenesulfinic chloride and 1.7 g cyclohexyl urea were treaed at room temp. for 20 min in 20ml pyridine to give N-[4-(β-(N'-methyl-N'-pyridyl-ureidoethyl)-benzenesulfonyl urea.
Abstract:
Title compds.(I, X = pyridyl, quinolyl, benzothiazolyl; R = C1-3 alkyl; R1 = C3-6 alkyl, C5-9 cycloalkyl, cycloalkenyl, bicyclohetyl, adamantyl or benzyl) useful as hypoglycemic agent, were prepd. by adding a group(III, X and R are given) to benzenesulfonylurea(II). Thus, 1.8g N-methyl-N-2-pyridyl-carbamic chloride was added to a mixt. 3.25gN-[4-β-aminoethyl) -benzenesulfonyl -N' -cyclohexylurea and 1 g pyridine in DMF, and heated to steam to give N-[4- (β-N'-methyl-N'-2-pyridyl-ureidoethyl)-benzenesulfonyl -N'-cyclohexylurea.
WHICH IN THE FREE FROM OR IN THE FORM OF THEIR SALTS HAVE BLOOD SUGAR LOWERING PROPERTIES AND ARE DISTINGUISHED BY A STRONG AND LONG-LASTING HYPOGLYCEMIC ACTION. IN THE FORMULA X REPRESENTS (R-O-),Z-PHENYL OR 3-(R-O-),5-Z''-THIEN-2-YL WHEREIN R STANDS FOR AN ALKYL GROUP HAVING 1 TO 4 CARBON ATOMS, Z STANDS FOR A HALOGEN ATOM, AN ALKYL OR ALKOXY GROUP BOTH HAVING 1 TO 4 CARBON ATOMS, AND Z'' STANDS FOR A HALOGEN ATOM OR AN ALKYL GROUP HAVING 1 TO 4 CARBON ATOMS.
WHEREIN X IS HYDROGEN, CHLORINE, BROMINE, METYL OR METHOXY, Y IS -CH(CH3)-CH3-, PREFERABLY
-CH2-CH2-,
Z IS HYDROGEN OR A HYDROCARBON RADICAL OF 1 OR 2 CARBON ATOMS, WHICH FORMS TOGETHER WITH A 5- OR 6-MEMBERED RING, R IS ALKYLENE-IMINO OF 3 TO 7 CARBON ATOMS IN THE RING WHICH MAY BE UNSATURATED OR SUBSTITUTED BY 1 OR 2 METHYL OR LOWER ALKYL OR METHOXY, PENTAMETHYLENIMINO SUBSTITUTED BY ENDOALKYLENE OF 1 TO 3 CARBON ATOMS, HEXAMETHYLENE-IMINO SUBSTITUTED BY ENDOETHYLENE IN B-EPOSITIONS, TETRAHYDRO-ISO-INDOLINE, 4,7 - ENDOALKYLENE-HEXAHYDRO- OR -TETRAHYDRO-ISO-INDOLINE, THE ENDOALKYLENE CONTAINING 1 OR 2 CARBON ATOMS AND THE DOUBLE BOND OF THE TETRAHYDRO COMPOUND BEING IN 5,6 POSITION, AND THE SALTS THEREOF.
Abstract:
The title compds. (I; X=pyridyl, pyrimidinyl, quinolyl, benzthiazolyl, benzoxazolyl; R=C1-3 alkyl; R1=C3-6 alkyl, C5-9 cycloalkyl, alkylcycloalkyl, cycloalkenyl, bicycloheptyl, bicycloheptenyl, ada-antyl, benzyl) were prepd. by hydrolysis of II (A=urea substitutent such as isourea ether). Thus, N-4-(-(N'-methvl-N'-2-pyridyl-ureido)-ethyl) benzenesulfonyl-N'-cyclohexyl thiourea was treated with HgO, COCl2 and conc. HCl to geve I(X=pyridyl; R=Me; R1=C6H11) which at 10mg/kg orally in rabbits decreased the blood sugar level by 43%, after 1 hr, 49% after 24 hr and 18% after 48 hr
Abstract:
Benzenesulfonyl ureas (I; X = pyridyl, pyrimidinyl, quinolyl, benzothiazolyl, benzoxazolyl; R = C1-3 alkyl; R1 = C3-6 alkyl, C5-9 cycloalkenyl, cycloalkeny, bicycloheptyl, adamantyl, benzyl), useful as hyperglycemic agent, were prepd. by substituting S with O from II-substituted benzenesulfonylthiourea. Thus, 5 g N-[4-(β-(N'-methyl-N'-pyridyl-ureido)-ethyl) benzenesulfonyl -N'-cyclohexyl-thiourea(4(β-